Astellas Pharma’s US$4.078 billion acquisition of OSI Pharmaceuticals
Advisers to Astellas: Citi
Advisers to OSI: Bank of America-Merrill Lynch; Lazard; Centerview Partners
The quest of Japanese companies for growth beyond a stagnant domestic economy with a rapidly ageing population is driving a boom in Japan cross-border M&A. Many potential
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.